Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
It targets fat cells, encouraging lipolysis (fat breakdown) and inhibiting lipogenesis (fat creation)
Sterile water isn't preserved
Research indicates that BPC-157 increases actin production at the gene level, while TB-500 acts as an actin-binding protein that facilitates cellular movement
The compound has never received market authorization in Canada or anywhere else, and Metabolic Pharmaceuticals terminated clinical development in 2007 after the Phase IIb obesity trial failed
This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment
US$ 29.82
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
US$ 24.55
US$ 23.12
